Introduction: Phacoemulsification and manual small incision cataract surgery (MSICS) are sutureless surgeries with low complication rates and satisfactory visual outcomes. Compared to phacoemulsification, MSICS, a cost effective surgical technique, could better suit high volume surgery scenario of resource-poor settings. Objective was to compare preoperative macular thickness of patients undergoing uncomplicated phacoemulsification and MSICS and again postoperatively on days 1, 7 and 40 using optical coherence tomography (OCT). Material and Methods: Randomized study at Rotary Eye Hospital, Malegaon. Patients of age 35-85years having undergone uneventful phacoemulsification or MSICS were included. Patients with co-existing ocular pathologies were excluded. Examination included indirect ophthalmoscopy, slit lamp biomicroscopy with 90 D lens and macular thickness measurements preoperatively and on days 1, 7 and 40postoperatively using OCT. Results: Mean macular thickness in MSICS group was 187.71+/-17.22 μm preoperatively and 201.91+/-18.95μm, 208.04+/-18.66μm, 215.25+/-19.38 μm, postoperatively on days 1, 7 and 40 respectively. Mean macular thickness in phacoemulsification group was 185.77+/-15.64 μm preoperatively and 195.77+/-17.38 μm, 199.05+/-16.87 μm, 203.76 +/-17.48 μm postoperatively on days 1, 7and 40 respectively. Postoperative macular thickness (days 1, 7 and 40) was significantly higher in the MSICS group (p= 0.013, p<0.000 and p<0.000 respectively). There was neither clinical, nor OCT evidence of cystoid macular edema in either group. Conclusion: The subclinical increase in macular thickness was higher following MSICS. However, final visual outcome remained unaffected. For resource-poor settings, MSICS still serves as a good means of offering comparable visual outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.